Breaking
Friday, June 19, 2026

Regulatory Compliance

🇪🇺 EMA

EMA news and analysis for pharmaceutical BD, investment, and market access

Navigate global pharma regulatory compliance. Get critical intelligence on FDA, EMA, and global health authority updates for your business strategy.

Showing 1–11 of 11 articles

Quick answer

NovaPharmaNews Regulatory Compliance hub for EMA covers 11 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.

High impact AnalysisJun 2, 2026

Eli Lilly's 340B Policy Shift: Impact on Hospital Networks and Pharma Strategy

9 min

Dr. Elena Rossi
High impact NewsMay 1, 2026

Bio-Rad Q1 2026 Results Show IVDR Compliance Costs Impact European Diagnostics Operations

2 min

Prof. Marcus Webb
High impact NewsApr 30, 2026

FDA Real-World Evidence Framework Shifts $10B Toward Validated Medtech Platforms Like VentriPoint

Medical Devices/Digital Health · 4 min

Dr. Lukas Schneider
High impact NewsApr 23, 2026

SamaCare Launches Industry-First Prior Authorization Performance Benchmarks for Medical Benefit Drugs

2 min

Prof. Marcus Webb
High impact NewsApr 23, 2026

Pet Service Holding Reports 2025 Annual Results Amid European Veterinary Regulatory Changes

2 min

Prof. Marcus Webb
High impact NewsApr 21, 2026

Pharmaceutical Isolators Market Reaches $7.82 Billion as EU GMP Annex 1 Drives Manufacturing Safety Requirements

2 min

Prof. Marcus Webb
High impact NewsApr 21, 2026

Mabwell Achieves First PIC/S GMP Compliance Certification from Jordan FDA for Biopharmaceutical Manufacturing

2 min

Prof. Marcus Webb
High impact NewsApr 20, 2026

EMA IRIS System Updates: New Account Requirements for PSUR Submissions Starting September 2025

EMA · 2 min

Dr. Elena Rossi
High impact NewsApr 16, 2026

Medical Device Software Compliance Training Launches for EU MDR, IVDR and FDA Regulations in June 2026

FDA · 2 min

Dr. Elena Rossi
High impact NewsApr 15, 2026

New Clinical Trial Monitoring Course Addresses Rising GCP Compliance Issues in Biopharmaceutical Industry

2 min

Prof. Marcus Webb
High impact NewsApr 15, 2026

New GCP Inspections Training Course Addresses ICH GCP E6(R3) and EU CTR Compliance for Pharmaceutical Companies

FDA · 2 min

Prof. Marcus Webb

Frequently asked questions

How often is this topic updated?

New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.

Where does this coverage come from?

Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.